US Stock MarketDetailed Quotes
EBS Emergent BioSolutions
- 11.200
- -0.230-2.01%
Close Jul 19 16:00 ET
- 11.200
- 0.0000.00%
Pre 05:57 ET
586.90MMarket Cap-1020P/E (TTM)
11.970High11.040Low2.78MVolume11.210Open11.430Pre Close31.69MTurnover5.41%Turnover RatioLossP/E (Static)52.40MShares12.74052wk High0.88P/B575.11MFloat Cap1.42052wk Low--Dividend TTM51.35MShs Float137.610Historical High--Div YieldTTM8.14%Amplitude1.420Historical Low11.408Avg Price1Lot Size
Emergent BioSolutions Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 85.30%292.4M | -4.93%1.02B | -16.47%269.9M | 18.65%264M | 40.74%331.3M | -47.03%157.8M | -34.36%1.08B | -49.00%323.1M | -28.71%222.5M | -36.74%235.4M |
| Operating revenue | 85.30%292.4M | -4.93%1.02B | -16.47%269.9M | 18.65%264M | 40.74%331.3M | -47.03%157.8M | -34.36%1.08B | -49.00%323.1M | -28.71%222.5M | -36.74%235.4M |
| Cost of revenue | -5.43%144.6M | 1.77%705.4M | -16.05%185.1M | 20.11%176.8M | 12.25%190.6M | -1.92%152.9M | -7.35%693.1M | 8.35%220.5M | -32.32%147.2M | -25.46%169.8M |
| Gross profit | 2,916.33%147.8M | -17.08%317.6M | -17.35%84.8M | 15.80%87.2M | 114.48%140.7M | -96.55%4.9M | -57.03%383M | -76.14%102.6M | -20.40%75.3M | -54.54%65.6M |
| Operating expense | -29.18%108M | -4.98%519.1M | -14.95%128.6M | -7.88%111.1M | -7.78%126.9M | 12.46%152.5M | 7.50%546.3M | 23.83%151.2M | -6.73%120.6M | 6.01%137.6M |
| Selling and administrative expenses | -16.39%84.7M | 8.51%368.4M | -3.96%89.7M | 5.13%86M | 12.70%91.4M | 19.46%101.3M | -2.64%339.5M | -1.16%93.4M | -0.37%81.8M | -11.07%81.1M |
| Research and development costs | -62.90%15.1M | -40.84%111.4M | -37.45%29.4M | -63.74%15.3M | -47.79%26M | -12.28%40.7M | -19.94%188.3M | -44.18%47M | -14.92%42.2M | 1.84%49.8M |
| Depreciation amortization depletion | -4.71%16.2M | 9.52%65.6M | -9.50%16.2M | 16.43%16.3M | 15.00%16.1M | 21.43%17M | 2.39%59.9M | 27.86%17.9M | -3.45%14M | -7.28%14M |
| -Depreciation and amortization | -4.71%16.2M | 9.52%65.6M | -9.50%16.2M | 16.43%16.3M | 15.00%16.1M | 21.43%17M | 2.39%59.9M | 27.86%17.9M | -3.45%14M | -7.28%14M |
| Other operating expenses | -23.08%-8M | 36.47%-26.3M | 5.63%-6.7M | 62.64%-6.5M | 9.59%-6.6M | 32.29%-6.5M | 69.15%-41.4M | 89.94%-7.1M | -2.96%-17.4M | 71.26%-7.3M |
| Operating profit | 126.96%39.8M | -23.39%-201.5M | 9.88%-43.8M | 47.24%-23.9M | 119.17%13.8M | -2,406.25%-147.6M | -142.63%-163.3M | -115.78%-48.6M | -30.55%-45.3M | -596.55%-72M |
| Net non-operating interest income expense | -35.75%-24.3M | -135.66%-87.9M | -69.53%-21.7M | -131.76%-19.7M | -266.67%-28.6M | -118.29%-17.9M | -8.12%-37.3M | -42.22%-12.8M | -1.19%-8.5M | 9.30%-7.8M |
| Non-operating interest expense | 35.75%24.3M | 135.66%87.9M | 69.53%21.7M | 131.76%19.7M | 266.67%28.6M | 118.29%17.9M | 8.12%37.3M | 42.22%12.8M | 1.19%8.5M | -9.30%7.8M |
| Other net income (expense) | -169.39%-3.4M | -2,301.09%-441.8M | 11M | -1,558.96%-222.3M | -7,746.67%-235.4M | 345.00%4.9M | 59.47%-18.4M | 0 | -458.33%-13.4M | -330.77%-3M |
| Special income (charges) | ---- | -6,626.87%-450.7M | --0 | ---218.9M | ---231.8M | ---- | 83.93%-6.7M | ---6.7M | --0 | --0 |
| -Less:Impairment of capital assets | ---- | 7,734.33%524.9M | --0 | --218.2M | --306.7M | ---- | -83.93%6.7M | --6.7M | --0 | --0 |
| -Gain on sale of business | ---- | --74.2M | --0 | ---700K | --74.9M | ---- | --0 | --0 | --0 | --0 |
| Other non- operating income (expenses) | -169.39%-3.4M | 176.07%8.9M | 64.18%11M | 74.63%-3.4M | -20.00%-3.6M | 345.00%4.9M | -216.22%-11.7M | 844.44%6.7M | -458.33%-13.4M | -330.77%-3M |
| Income before tax | 107.53%12.1M | -233.88%-731.2M | 11.24%-54.5M | -295.68%-265.9M | -202.17%-250.2M | -4,126.32%-160.6M | -172.23%-219M | -123.96%-61.4M | -47.69%-67.2M | -1,250.00%-82.8M |
| Income tax | -87.89%3.1M | 495.95%29.3M | -189.29%-5M | -112.56%-2.5M | 142.05%11.1M | 25,700.00%25.6M | -108.84%-7.4M | -92.86%5.6M | 255.47%19.9M | -1,115.38%-26.4M |
| Net income | 104.83%9M | -259.40%-760.5M | 26.12%-49.5M | -202.41%-263.4M | -363.30%-261.3M | -4,932.43%-186.2M | -196.40%-211.6M | -137.66%-67M | -166.36%-87.1M | -1,326.09%-56.4M |
| Net income continuous Operations | 104.83%9M | -259.40%-760.5M | 26.12%-49.5M | -202.41%-263.4M | -363.30%-261.3M | -4,932.43%-186.2M | -196.40%-211.6M | -137.66%-67M | -166.36%-87.1M | -1,326.09%-56.4M |
| Minority interest income | ||||||||||
| Net income attributable to the parent company | 104.83%9M | -259.40%-760.5M | 26.12%-49.5M | -202.41%-263.4M | -363.30%-261.3M | -4,932.43%-186.2M | -196.40%-211.6M | -137.66%-67M | -166.36%-87.1M | -1,326.09%-56.4M |
| Preferred stock dividends | ||||||||||
| Other preferred stock dividends | ||||||||||
| Net income attributable to common stockholders | 104.83%9M | -259.40%-760.5M | 26.12%-49.5M | -202.41%-263.4M | -363.30%-261.3M | -4,932.43%-186.2M | -196.40%-211.6M | -137.66%-67M | -166.36%-87.1M | -1,326.09%-56.4M |
| Basic earnings per share | 104.58%0.17 | -251.90%-14.85 | 46.02%-0.95 | -190.29%-5.08 | -355.75%-5.15 | -5,200.00%-3.71 | -202.93%-4.22 | -149.72%-1.76 | -186.89%-1.75 | -1,355.56%-1.13 |
| Diluted earnings per share | 104.58%0.17 | -251.90%-14.85 | 46.02%-0.95 | -190.29%-5.08 | -355.75%-5.15 | -5,200.00%-3.71 | -203.94%-4.22 | -150.29%-1.76 | -186.89%-1.75 | -1,355.56%-1.13 |
| Dividend per share | ||||||||||
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg